diffuse parenchymal lung disease

36
Case Approach in Interstitial Lung Diseases Suree Sompradeekul, MD, FCCP Assistant Professor of Medicine Division of Respiratory Disease & Tuberculosis Dept of Medicine, Siriraj Hospital

Upload: weera-wee

Post on 14-Oct-2014

174 views

Category:

Documents


2 download

DESCRIPTION

ild

TRANSCRIPT

Page 1: Diffuse Parenchymal Lung Disease

Case Approach in Interstitial

Lung DiseasesSuree Sompradeekul, MD, FCCPAssistant Professor of Medicine

Division of Respiratory Disease & TuberculosisDept of Medicine, Siriraj Hospital

Page 2: Diffuse Parenchymal Lung Disease

Diffuse Diffuse parenchymalparenchymal lung diseaselung disease

DPLD of known DPLD of known cause or associationcause or association

Idiopathic Idiopathic interstitial interstitial

pneumoniaspneumonias

GranulomatousGranulomatous Other forms of Other forms of interstitial pneumonia interstitial pneumonia

e.g. LAM, PLCH, e.g. LAM, PLCH, eosinophiliceosinophilic

pneumonia, etc.pneumonia, etc.Idiopathic Idiopathic pulmonary pulmonary

fibrosis fibrosis

Interstitial pneumonia Interstitial pneumonia other than idiopathicother than idiopathicpulmonary fibrosispulmonary fibrosis

DesquamativeDesquamative interstitialinterstitialpneumonia pneumonia

Respiratory Respiratory bronchiolitisbronchiolitisInterstitial lung diseaseInterstitial lung disease

Acute interstitial Acute interstitial pneumonia pneumonia

Cryptogenic Cryptogenic organisingorganising pneumoniapneumonia

NonNon--specificspecificInterstitial pneumoniaInterstitial pneumonia

LymphocyticLymphocyticInterstitial pneumoniaInterstitial pneumonia

Page 3: Diffuse Parenchymal Lung Disease

ILD associated with systemic diseaseRheumatogical

Systemic sclerosisRheumatoid arthritisSystemic lupus erythematosusSjÖgren’s syndromeAnkylosing spondylitisPolymyositis/dermatomyositisMixed connective tissue disease

VasculitisGiant cell arteritisTakayasu’s arteritisMicroscopic polyangiitisWegener’s granulomatosisChurg-Strauss granulomatosisBehcet’s syndromePulmonary-renal syndrome (including Goodpasture’s syndrome)Capillaritis

Page 4: Diffuse Parenchymal Lung Disease

ILD associated with systemic disease

Vascular Antiphospholipid syndromeCoagulopathiesArteriovenous malformationsPrimary pulmonary hypertensionIdiopathic pulmonary hemosiderosisPulmonary veno-occlusive disease

Page 5: Diffuse Parenchymal Lung Disease

Disease caused by environmental triggers or drug ingestion

Drug*ChemotherapeuticCardiovascularAntibioticsAnti-inflammatoryIllicitPsychotropicRadiationPesticidesOxygen

Environmental (organic causes)Extrinsic allergic alveolitis

FungalBacterialAvianChemical

Inorganic causesFibrogenic inorganic dusts

AsbestosSilicaHard metal alloyBerylliumCoalAluminium

Non-fibrogenicSiderosisStannosisBaritosisAntimony

Page 6: Diffuse Parenchymal Lung Disease

Idiopathic interstitial pneumoniasIdiopathic pulmonary fibrosis (or cryptogenic fibrosing alveolitis)Desquamative interstitial pneumonia (DIP)Acute interstitial pneumonia (AIP)Non-specific interstitial pneumonia (NSIP)Respiratory bronchiolitis/interstitial lung disease (RB-ILD)Cryptogenic organising pneumonia (COP or idiopathic BOOP)Lymphocytic interstitial pneumonia (LIP)

Page 7: Diffuse Parenchymal Lung Disease

Histologic & Clinical Classification of ILDHistologic patterns Clinical-Radiologic-

Pathologic DxUsual interstitial pneumonitis

Nonspecific interstitial pneumoniaOrganizing pneumonia

Diffuse alveolar damageRespiratory bronchiolitis

Desquamative interstitial pneumoniaLymphoid interstitial pneumonia

Idiopathic pulmonary fibrosis/cryptogenic fibrosing alveolitisNonspecific interstitial pneumonia (provisional)Cryptogenic organizing pneumonia (BOOP)Acute interstitial pneumoniaRespiratory bronchiolitis interstitial lung diseaseDesquamative interstitial pneumonia

Lymphoid interstitial pneumonia

Page 8: Diffuse Parenchymal Lung Disease

Granulomatous diseasesSarcoidosisBerylliosisHypersensitivity pneumonitis or Extrinsic allergic alveolitisLangerhan’s cell histiocytosisWegener’s granulomatosisChurg-Strauss syndromeLymphomatoid granulomatosisBronchocentric granulomatosis

Page 9: Diffuse Parenchymal Lung Disease

Other diffuse lung diseasesInherited disorders

Tuberous sclerosisNeurofibromatosisHermansky-Pudlak syndromeLipid storage disordersFamilial fibrosing alveolitis

Pulmonary eosinophiliaKnown causes, e.g. fungi, parasites, drugsUnknown causes, e.g. acute and chronic idiopathic

eosinophilic pneumoniaLymphangioleiomyomatosisAlveolar proteinosisAlveolar microlithiasisAmyloidosisChronic aspirationChronic left heart failure

Page 10: Diffuse Parenchymal Lung Disease

Clinical manifestationProgressive dyspneaNon-productive coughPleuritic chest pain (pneumothorax)Hemoptysis +/- Fe def anemiaWheezingAbnormal CXRSymptoms related to associated diseases e.g. CNTRestrictive pattern from spirometry

Page 11: Diffuse Parenchymal Lung Disease

Physical examinationIncreased RRRespiratory distressCracklesInspiratory squeaks – late inspiratoryhigh-pitched rhonchi; bronchiolitisCyanosis, clubbing of fingers, corpulmonale – advanced diseaseExtrapulmonary findings

Page 12: Diffuse Parenchymal Lung Disease

Extrapulmonary findingsHypertensionSkin: EN, maculopapular rash, heliotrope, telangiectasis, Raynaud’s, Café-au-lait spots, vasculitis, subcut nodules, albinism, calcinosisEye: uveitis, scleritis, keratoconjunctivitissiccaSalivary gland enlargementLymphadenopathyHepatospenomegalyPericarditis, myocarditisMuscle weakness

Page 13: Diffuse Parenchymal Lung Disease
Page 14: Diffuse Parenchymal Lung Disease

Duration of illnessAcute (days to weeks)

Acute idiopathic interstitial pneumonia (AIP, Hammon-Rich syndrome)Eosinophilic pneumoniaHypersensitivity pneumoniaBronchiolitis obliterans with organizing pneumonia (BOOP) or cryptogenic organizing pneumonia (COP)

Subacute (weeks to months)SarcoidosisDrug-inducedAlveolar hemorrhage syndromesIdiopathic BOOPCNT (SLE, polymyositis)

Chronic (months to years)Idiopathic pulmonary fibrosis (IPF)SarcoidosisPulmonary Langerhans cell histiocytosis (PLCH) or eosinophilicgranuloma (EG)

Page 15: Diffuse Parenchymal Lung Disease

Occupation & environmental exposures

Inhaled organic dusts (hypersensitivity pneumonitis)

Thermophilic fungi; farmer’s lung, grain handler’s lung, humidifier or air conditioner lungBacteria (Bacillus spp); humidifier lungTrue fungi (aspergillus, cryptostorma coricale, penicilliumAnimal proteins; bird fancier’s disease

Page 16: Diffuse Parenchymal Lung Disease

Occupation & environmental exposuresInhaled inorganic dust

SilicatesSilica (silicosis)Asbestosis (asbestosis)Talc (talcosis)Kaolin or china clayDiatomaceous earth (Fuller’s earth)Nepheline (hard rock)Aluminum silicates (sericite, sillimanite, ziolite)Portland cementMicaBeryllium (berylliosis)

CarbonCoal dust (pneumoconiosis)graphite

MetalsTins (stannosis)Aluminum; powdered aluminum, bauxiteHard metal dusts: cadmium, titanium, tungsten, hafnium, niobium, cobalt, vanadium carbidesIron (siderosis, arc welder’s lung)AntimonyHematite (siderosilicosis)Mixed dusts of silver and iron oxide (argyrodiserosis)Barium (powder of baryteor BaSO4- (baritosis)CuSO4 neutralized with hydrated lime (vineyard sprayer’s lung)Rare earths, Ocerium scandium, yttrium , lanthanum

Page 17: Diffuse Parenchymal Lung Disease

Occupation & environmental exposuresInhaled other agents

Chemical sourcesSynthetic-fiber lung (nylon, acrylic, polyesters, orlon)Bakelite worker’s lungVinyl chloride, polyvinyl chloride powder

GasesOxygenOxides of nitrogensulfur dioxideChlorine gasesMethyl isocyanate

FumesOxides of zinc, copper, manganese, cadmium, iron, magnesium, nickel, brass, selenium, tin, antimonyDiphenylmethane diisocyanateTrimellitic anhydride toxicity

VaporsHydrocarbonsThermosetting resins (rubber tire workers)Toluene diisocyanate (TDI-asthmatic reactions prominent)Mercury

AerosolsOilsFatsPyrethrum (natural insecticide)

Page 18: Diffuse Parenchymal Lung Disease
Page 19: Diffuse Parenchymal Lung Disease
Page 20: Diffuse Parenchymal Lung Disease

Laboratory dataLeukopenia: sarcoidosis, CNT, lymphoma, drug-inducedLeukocytosis: HP, lymphoma, vasculitisEosinophilia: eosinophilic pneumonia, sarcoidosis, vasculitis, drug-induced (sulfa, methotrexate)Thrombocytopenia: sarcoidosis, CNT, drug-induced, Gaucher’s disHemolytic anemia: CNT sarcoidosis, lymphoma, drug-inducedNormocytic anemia: alv hemorrhage syndrome, CNT, lymphangitic carcinomatosisElevated LDH: alv proteinosis, IPFHypogammaglobulinemia: LIPHypergammaglobulinemia: CNT,sarcoidosis, vasculitis, LIP, lymphoma, silicosis

Page 21: Diffuse Parenchymal Lung Disease

Laboratory dataSerum immune complexes: IPF, LIP, vasculitis, CNT, EGACE: sarcoidosis, HP, silicosis, Gaucher’s diseaseAntibasement membrane Ab (anti-GBM):Goodpasture’s syndromeANCA: Wegener’s granulomatosis, Churg-Strauss syndrome, microscopic polyangiitisSerum precipitating Ab: HPLymphocyte transformation test to specific antigens: chronic beryllium disease, aluminum potroom workers disease, gold-induced pneumonitis

Page 22: Diffuse Parenchymal Lung Disease
Page 23: Diffuse Parenchymal Lung Disease
Page 24: Diffuse Parenchymal Lung Disease
Page 25: Diffuse Parenchymal Lung Disease
Page 26: Diffuse Parenchymal Lung Disease

IPFIPF DIPDIP RBRB--ILDILD AIPAIP BOOPBOOP NSIPNSIP

Age (years) 65 40 35 50 55 55

Occurrence in children

No Rare No Rare No Occasional

Onset Chronic Chronic Chronic Acute Acute/subacute

Subacute/Chronic

Clubbing Frequent Frequent No No No Occasional

Fever Rare No No 50% 70% 20%

Mortality (%) 70 27 0 8 13 11

Mean survival 2.8 years 12 years Not reduced

1.5 months

> 10 years

13 years

Response to corticosteroids

Poor Good Good Poor Good Good

Page 27: Diffuse Parenchymal Lung Disease

Disease Radiographic features CT Differential Dx

IPF Peripheral, basal reticular abnormalities with volume loss

Asbestosis, CNT, HP, sarcoidosis

DIP Ground glass opacity RB-ILD, HP, sarcoidosis, PCP

RB-ILD Bronchial wall thickening, ground glass opacity

DIP, NSIP, HP

AIP Progressive diffuse ground glass density/consolidation

Hydrostatic edema, pneumonia, acute eosinophilic pneumonia

COP Patchy bilateral consolidation Infection, vasculitis, sarcoidosis, alveolar carcinoma, lymphoma, eosinophilic pneumonia, NSIP

LIP Reticular opacity, nodules Sarcoidosis, lymphangiticcarcinomatosis, PLCH

NSIP Ground glass and reticular opacity

UIP, DIP, COP, HP

Page 28: Diffuse Parenchymal Lung Disease

Disease Distribution CT Pattern

IPF Peripheral, subpleural, basal Reticular, honeycombing, traction bronchiectasis, minor focal ground-glass

DIP Peripheral, subpleural, basal Predominant ground glass, minor reticular lines

RB-ILD Diffuse Bronchiolar-wall thickening, centrilobular nodules, patchy ground-glass

AIP Diffuse Ground glass with focal lobular sparing, consolidation, later traction bronchiectasis

COP Subpleural, peribronchial Patchy consolidation and/or nodules

LIP Diffuse Centrilobular nodules, ground glass attenuation, septal and bronchial wall thickening, thin-walled cysts

NSIP Peripheral, subpleural Predominant ground glass, basal reticular lines, consolidation

Page 29: Diffuse Parenchymal Lung Disease

Acute interstitial pneumoniaDiffuse alveolar hemorrhage (vasculitis or coagulopathy most common causes)Acute pneumonia due to rheumatological diseaseDrugs (selected)Eosinophilic lung disease, acute or chronicCryptogenic and known causes of organizing pneumonia (BOOP)Mimics

− Pulmonary edema of any cause− Infection, especially opportunistic with

Pneumocystis carinii− Acute respiratory distress syndrome

Acute onset ILD

Page 30: Diffuse Parenchymal Lung Disease

Diffuse lung disease with characteristic features on HRCT

Idiopathic pulmonary fibrosis (cryptogenic fibrosing alveolitis)Desquamative interstitial pneumoniaExtrinsic allergic alveolitisSarcoidosisLangerhans cell histiocytosisLymphangioleiomyomatosisAlveolar proteinosisLymphangitic carcinomatosis

Page 31: Diffuse Parenchymal Lung Disease

Predominant distribution on HRCTUpper-lobe predominance Sarcoidosis

Coalworker’s pneumoconiosisSilicosisEosinophilic pneumoniaLangerhans cell histiocytosisExtrinsic allergic alveolitis

Lower-lobe predominance Idiopathic pulmonary fibrosisDesquamative interstitial pneumonia AsbestosisCollagen vascular disease

Peripheral predominance Idiopathic pulmonary fibrosisDesquamative interstitial pneumoniaAsbestosisCollagen vascular diseaseEosinophilic pneumoniaOrganising pneumonia

Central (peribronchovascular) predominance

SarcoidosisLymphangitis carcinomatosis

Page 32: Diffuse Parenchymal Lung Disease

Pattern in HRCTLinear and reticular Idiopathic pulmonary fibrosis

Collagen vascular diseaseAsbestosis

Nodular or reticulonodular SarcoidosisSilicosisLymphangitis carcinomatosis

Parenchymal opacification(consolidation/ground-glass)

Organising pneumoniaExtrinsic allergic alveolitisDesquamative interstitial pneumoniaRespiratory bronchiolitis/interstitial lung

diseaseChronic eosinophilic pneumonia HaemorrhageAlveolar proteinosis

Cystic abnormalities Langerhans cell histiocytosisLymphangioleiomyomatosis

Page 33: Diffuse Parenchymal Lung Disease

Neutrophilic(± eosinophilic)

Idiopathic pulmonary fibrosis Desquamative interstitial pneumonia Collagen vascular diseaseAsbestosisAcute interstitial pneumonia

Lymphocytic SarcoidosisExtrinsic allergic alveolitisSilicosisLymphocytic interstitial pneumonia

Eosinophilic (Chronic) eosinophilic pneumonia Churg-Strauss syndromeHypereosinophilic syndrome

Mixed cellularity Bronchiolitis obliterans organizing pneumoniaCollagen/vascular diseaseNon-specific interstitial pneumonia

Abnormal macrophage morphology

Extrinsic allergic alveolitisAlveolar proteinosisRespiratory bronchiolitis/interstitial lung diseaseAlveolar hemorrhage

BAL cell

Page 34: Diffuse Parenchymal Lung Disease
Page 35: Diffuse Parenchymal Lung Disease

Initial assessment:• Breathlessness• Crackles on auscultation• Pulmonary function: reduced

TL CO, restrictive defect• Chest radiograph: compatible

with interstitial fibrosis• Absence of environmental or systemic disease cause

• High-resolution CT• Bronchoalveolar lavage± transbronchial biopsy

Diagnosis and prognosis

Yes No

Thoracoscopic or open lung biopsy

• Reversible disease on biopsy or CT ?• Progressive disease ?• Moderate functional impairment ?

Yes No

Treat If deteriorates

Observe (but monitor with serial pulmonary function tests)

Page 36: Diffuse Parenchymal Lung Disease

Thank you & GOOD LUCK !!!!!